Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Efficacy and Safety of Phentermine/Topiramate in Youth with Hypothalamic Obesity

Study ID: NCT06299891
Start Date: 2025-03-01
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Phentermine / Topiramate Extended Release Oral Capsule [Qsymia]

Placebo

Sponsor

Seattle Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Study ID: NCT05006794
Start Date: 2021-09-15
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

195

Intervention / Treatment

zamzetoclax

Docetaxel

sacituzumab Govitatan-Kzius

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Study ID: NCT06408194
Start Date: 2024-05-13
End Date: 2025-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

CD22CART infusion

Tisagenlecleucel

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Study ID: NCT05361694
Start Date: 2022-04-12
End Date: 2027-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

Study ID: NCT06859762
Start Date: 2025-07
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

220

Intervention / Treatment

YL217 every 3 weeks (Q3W) intravenous (IV) infusion

Sponsor

MediLink Therapeutics (Suzhou) Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Study ID: NCT05608291
Start Date: 2023-01-16
End Date: 2030-02-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1530

Intervention / Treatment

Familimab

Cemiplimab

Pembrolizumab

Placebo

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap

Study ID: NCT06915662
Start Date: 2025-04
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Tulavi allay Nerve Cap

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Trial of Ixazomib for Kaposi Sarcoma

Study ID: NCT04305691
Start Date: 2023-11-07
End Date: 2029-03-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

Ixazomib Citrate

Quality-of-Life Assessment

Administration questionnaire

Sponsor

AIDS Malignancy Consortium

Source: clinicaltrials.gov

Share:
Add to list

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

Study ID: NCT05138991
Start Date: 2022-06-22
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Echocardiogram Recording

Administration questionnaire

Stress Cardiac Magnetic Resonance Imaging

Wireless Synchronized Cardiac Function Monitoring Device

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Cervical Cancer Prevention for Black Adults

Study ID: NCT04927494
Start Date: 2023-01-01
End Date: 2025-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Health is Wealth: A Cervical Health Program

Sponsor

Adebola Adebola

Source: clinicaltrials.gov

Share:
Add to list